Funding Rounds
Abalos Therapeutics

Abalos Therapeutics Series A (2019, $13M)

Abalos Therapeutics

Developer of new immuno-virotherapies focused on treating cancer.

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series A

Raised Amount: $13.26M

Raised Date: 2019-01-01